CALEB MASON: Open Payments
NPI 1083170807 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,807 in 164 payments from 17 companies in 2025. Trend: 2023 $1,808 · 2024 $2,728 · 2025 $2,807
Food & beverage: $2,698Education: $109
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $381 |
| Novartis Pharmaceuticals Corporation | 21 | $366 |
| LEO Pharma Inc. | 18 | $346 |
| ABBVIE INC. | 20 | $285 |
| UCB, Inc. | 17 | $261 |
| Janssen Biotech, Inc. | 18 | $248 |
| Lilly USA, LLC | 18 | $240 |
| PFIZER INC. | 13 | $195 |
| GENZYME CORPORATION | 4 | $103 |
| Galderma Laboratories, L.P. | 6 | $100 |
Products named: ILUMYA, COSENTYX, TREMFYA, Bimzelx, ADBRY, TALTZ, SKYRIZI, CIBINQO.
Industry payments across AR — which companies pay providers there.
